Now that 2021 is behind us, we can collectively exhale and hope for better things in the new year.
But despite inflation hitting a 39-year-high, despite incredible uncertainty from the Federal Reserve and despite wild volatility accompanying each new COVID-19 variant … last year wasn’t all bad. Our team of editors and analysts kept you dialed into the market’s pulse, providing 52 weeks of insight, expertise and investment opportunities.
Now, as we move into 2022, here are this week’s top stories from your favorite Weiss Ratings experts.
Biotech Miracles for Your Portfolio
Spiders’ webs and identifying new COVID-19 strains. Penny stocks and blue chips. The biotech sector has it all, and Senior Editor Sean Brodrick shares two investment opportunities that could be portfolio miracles in the near future.
This week, Financial News Anchor Jessica Borg interviews Kenny Polcari, the dynamic host of The Weiss Investor Podcast, a new series featuring financial bloggers, entrepreneurs, bankers, business leaders and broadcast journalists.
In 2020, a researcher at Bryn Mawr College conducted an experiment tracking Yankee Candle reviews before and during the pandemic. The result? An indication of the pandemic’s effect on some stocks. Research Analyst Kelly Green dives into the Weiss Ratings and tells you more.
As we bid farewell to 2021, here is a recap of Senior Editor Tony Sagami’s Top 10 stories of the past year, covering everything from inflation hedges to infrastructure projects, from killer innovation to rebounding fossil fuels.
How to Get More Passive Income in 2022
It looks like Senior Editor Mike Larson’s recommendation not to sweat the Omicron or Federal Reserve news paid off. Santa showed up after all, and this week, he has more tips on how to maximize passive income in 2022.
Until next week,
The Weiss Ratings Team